BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, February 20, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

April 26, 2006

View Archived Issues

Novel anti-Trx-1 reductase prodrugs demonstrate antitumor activity

Read More

Preclinical profile of promising clinical candidate ACP-103

Read More

No serious side effects in ongoing phase II study of NX-1207

Read More

FDA review of Keflex sNDA ongoing

Read More

Spectrum closes acquisition of Targent oncology assets

Read More

Boston Scientific completes combination with Guidant

Read More

New phase IIIb extension trial for Acapodene

Read More

NDA submission planned for room-temperature formulation of MNTX

Read More

Astellas closes CNS research in Edinburgh

Read More

FAST I phase III trial of icatibant for HAE completes randomization

Read More

BioVant shows potential as adjuvant for avian flu vaccine

Read More

U.S. study of NOV-205 for hepatitis C cleared to begin

Read More

Stem cell therapy product PLX-1 investigated in new preclinical study

Read More

FDA extends review for Sparlon in ADHD

Read More

Alcon and Amgen collaborate on therapeutics for eye diseases

Read More

Neuropharma advances NP-031112 for Alzheimer's disease into clinic

Read More

Fesoterodine superior to tolterodine in overactive bladder trial

Read More

Urinary incontinence improved by cizolirtine in overactive bladder patients

Read More

Pfizer announces new tolterodine study and releases data on overactive bladder prevalence

Read More

CYT005-AllQbG10 shows long-term efficacy in house dust mite allergy patients

Read More

TG-4001 enables avoidance of surgery in CIN2/3 patients

Read More

Amitiza now available for chronic idiopathic constipation

Read More

Novel treatment options for autoimmune disorders described in recent patent literature

Read More

Recent patents report new treatments for gastrointestinal disorders

Read More

New androgen receptor antagonists emerge from Pfizer R&D

Read More

PharmaMar presents preclinical data on its new Kahalalide F derivative

Read More

Arius Research presents data on their new anticancer antibodies

Read More

Popular Stories

  • Today's news in brief

    BioWorld
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • Illustration of brain and antibodies

    VST Bio’s VB-001 is neuroprotector after stroke

    BioWorld Science
    At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing